CD2AP Gene Focal segmental glomerulosclerosis type 3 Genetic Test
Welcome to DNA Labs UAE, where we offer the CD2AP Gene Focal segmental glomerulosclerosis type 3 Genetic Test. This test is designed to diagnose and provide valuable information about FSGS type 3, a rare genetic disorder that affects the kidneys.
Test Details
The CD2AP gene is associated with focal segmental glomerulosclerosis (FSGS) type 3, a rare genetic disorder that affects the kidneys. FSGS is characterized by scarring and damage to the glomeruli, which are the tiny filtering units in the kidneys.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes. In the context of FSGS type 3, NGS genetic testing can be used to identify mutations or variations in the CD2AP gene that may be responsible for the development of the condition.
By analyzing the CD2AP gene using NGS technology, healthcare providers can determine if a person has a genetic mutation or variation that is associated with FSGS type 3. This information can be helpful in diagnosing the condition, predicting disease progression, and guiding treatment decisions.
Test Components and Price
- Components: CD2AP Gene Focal segmental glomerulosclerosis type 3 Genetic Test
- Price: 4400.0 AED
Sample Condition and Report Delivery
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
Test Type and Doctor
- Test Type: Hepatology Nephrology Endocrinology Disorders
- Doctor: General Physician
Test Department
Genetics
Pre Test Information
Clinical History of Patient who is going for CD2AP Gene Focal segmental glomerulosclerosis type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CD2AP Gene Focal segmental glomerulosclerosis type 3 NGS Genetic DNA Test gene CD2AP.
Who Should Get Tested?
It’s important to note that genetic testing for FSGS type 3 is typically performed in individuals who have symptoms or a family history of the condition. A genetic counselor or healthcare provider can provide more information about the specific indications, benefits, and limitations of CD2AP gene testing for FSGS type 3.
| Test Name | CD2AP Gene Focal segmental glomerulosclerosis type 3 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Hepatology Nephrology Endocrinology Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CD2AP Gene Focal segmental glomerulosclerosis type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CD2AP Gene Focal segmental glomerulosclerosis type 3 NGS Genetic DNA Test gene CD2AP |
| Test Details |
The CD2AP gene is associated with focal segmental glomerulosclerosis (FSGS) type 3, a rare genetic disorder that affects the kidneys. FSGS is characterized by scarring and damage to the glomeruli, which are the tiny filtering units in the kidneys. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes. In the context of FSGS type 3, NGS genetic testing can be used to identify mutations or variations in the CD2AP gene that may be responsible for the development of the condition. By analyzing the CD2AP gene using NGS technology, healthcare providers can determine if a person has a genetic mutation or variation that is associated with FSGS type 3. This information can be helpful in diagnosing the condition, predicting disease progression, and guiding treatment decisions. It’s important to note that genetic testing for FSGS type 3 is typically performed in individuals who have symptoms or a family history of the condition. A genetic counselor or healthcare provider can provide more information about the specific indications, benefits, and limitations of CD2AP gene testing for FSGS type 3. |
